MYPOP

gene
On this page

Also known as P42pop

Summary

MYPOP (Myb related transcription factor, partner of profilin, HGNC:20178) is a protein-coding gene on chromosome 19q13.32, encoding Myb-related transcription factor, partner of profilin (Q86VE0). Transcriptional repressor; DNA-binding protein that specifically recognizes the core sequence 5’-YAAC[GT]G-3'.

Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in negative regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.

Source: NCBI Gene 339344 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 81 total
  • MANE Select transcript: NM_001012643

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20178
Approved symbolMYPOP
NameMyb related transcription factor, partner of profilin
Location19q13.32
Locus typegene with protein product
StatusApproved
AliasesP42pop
Ensembl geneENSG00000176182
Ensembl biotypeprotein_coding
OMIM617861
Entrez339344

Gene structure

Transcript identifiers

Ensembl transcripts: 4 — 4 protein_coding

ENST00000322217, ENST00000904793, ENST00000904794, ENST00000904795

RefSeq mRNA: 1 — MANE Select: NM_001012643 NM_001012643

CCDS: CCDS33055

Canonical transcript exons

ENST00000322217 — 3 exons

ExonStartEnd
ENSE000012433424589002345891323
ENSE000013341604590127545901825
ENSE000013341654590257045902613

Expression profiles

Bgee: expression breadth ubiquitous, 180 present calls, max score 90.46.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 12.4588 / max 76.0922, expressed in 1796 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
18158612.16401793
1815880.148569
1815870.146465

Top tissues by expression

237 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
oocyteCL:000002390.46gold quality
ileal mucosaUBERON:000033190.14gold quality
tibialis anteriorUBERON:000138588.43silver quality
right frontal lobeUBERON:000281087.94gold quality
secondary oocyteCL:000065587.70gold quality
Brodmann (1909) area 9UBERON:001354086.91gold quality
anterior cingulate cortexUBERON:000983586.48gold quality
dorsolateral prefrontal cortexUBERON:000983485.15gold quality
prefrontal cortexUBERON:000045184.89gold quality
apex of heartUBERON:000209884.65gold quality
frontal cortexUBERON:000187084.61gold quality
hindlimb stylopod muscleUBERON:000425284.44gold quality
neocortexUBERON:000195084.36gold quality
gastrocnemiusUBERON:000138884.29gold quality
right hemisphere of cerebellumUBERON:001489083.70gold quality
muscle of legUBERON:000138383.25gold quality
cerebral cortexUBERON:000095683.11gold quality
lower esophagus mucosaUBERON:003583483.11gold quality
granulocyteCL:000009483.01gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099182.85gold quality
amygdalaUBERON:000187682.67gold quality
cerebellar hemisphereUBERON:000224582.50gold quality
cerebellar cortexUBERON:000212982.44gold quality
postcentral gyrusUBERON:000258181.94gold quality
nucleus accumbensUBERON:000188281.70gold quality
cerebellumUBERON:000203781.67gold quality
superior frontal gyrusUBERON:000266181.56gold quality
putamenUBERON:000187481.44gold quality
forebrainUBERON:000189081.32gold quality
Ammon’s hornUBERON:000195481.06gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.87

Regulation

Is transcription factor: yes

JASPAR motifs

MotifNameFamily
MA2535.1MYPOPMyb-SANT

JASPAR matrix evidence (PMIDs): PMID:39605530

miRNA regulators (miRDB)

47 targeting MYPOP, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4692100.0067.322066
HSA-MIR-4673100.0066.641490
HSA-MIR-451499.9967.101870
HSA-MIR-4645-5P99.9865.811284
HSA-MIR-6825-5P99.9669.813431
HSA-MIR-6809-3P99.9171.453814
HSA-MIR-129799.9173.413162
HSA-MIR-4753-3P99.9071.033786
HSA-MIR-4731-5P99.8967.232537
HSA-MIR-391999.8769.452489
HSA-MIR-10395-5P99.8667.35676
HSA-MIR-6515-3P99.8268.191933
HSA-MIR-26A-5P99.7873.522303
HSA-MIR-26B-5P99.7873.512305
HSA-MIR-6763-5P99.7664.681767
HSA-MIR-3150A-3P99.7664.441640
HSA-MIR-2116-3P99.7464.32889
HSA-MIR-317599.6566.302031
HSA-MIR-6715B-5P99.6469.631420
HSA-MIR-426999.5569.891373
HSA-MIR-444199.4966.563216
HSA-MIR-94099.3766.142064
HSA-MIR-135A-5P99.3671.851601
HSA-MIR-135B-5P99.3671.631613
HSA-MIR-532-3P99.3465.761195
HSA-MIR-6808-5P99.3166.232150
HSA-MIR-6893-5P99.3166.252119
HSA-MIR-427099.0266.261987
HSA-MIR-4742-5P98.8968.411542
HSA-MIR-4755-3P98.7765.591915

Cross-species orthologs

1 orthologs

OrganismSymbolGene ID
mus_musculusMypopENSMUSG00000048481

Protein

Protein identifiers

Myb-related transcription factor, partner of profilinQ86VE0 (reviewed: Q86VE0)

Alternative names: Myb-related protein p42POP, Partner of profilin

All UniProt accessions (1): Q86VE0

UniProt curated annotations — full annotation on UniProt →

Function. Transcriptional repressor; DNA-binding protein that specifically recognizes the core sequence 5’-YAAC[GT]G-3’. Dimerization with PFN1 reduces its DNA-binding capacity.

Subunit / interactions. Interacts with PFN1. Homodimer and heterodimer with PFN1.

Subcellular location. Nucleus.

Domain organisation. The proline-rich region is required for PFN1 interaction.

RefSeq proteins (1): NP_001012661* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001005SANT/MybDomain
IPR028002Myb_DNA-bind_5Domain
IPR052870Myb-related_repressorFamily

Pfam: PF13873

UniProt features (16 total): compositionally biased region 7, region of interest 4, short sequence motif 3, chain 1, domain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q86VE0-F165.800.21

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 60 (showing top): GSE45365_NK_CELL_VS_CD8A_DC_DN, AAGCCAT_MIR135A_MIR135B, PATIL_LIVER_CANCER, GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOMF_DNA_BINDING_TRANSCRIPTION_REPRESSOR_ACTIVITY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, EBNA1BP2_TARGET_GENES, ID2_TARGET_GENES, SALL4_TARGET_GENES, ZNF282_TARGET_GENES, MIR135A_5P, MIR135B_5P

GO Biological Process (2): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of transcription by RNA polymerase II (GO:0006357)

GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), identical protein binding (GO:0042802), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), protein binding (GO:0005515)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
RNA polymerase II transcription regulatory region sequence-specific DNA binding3
regulation of transcription by RNA polymerase II2
transcription by RNA polymerase II2
regulation of DNA-templated transcription2
negative regulation of DNA-templated transcription1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
negative regulation of transcription by RNA polymerase II1
DNA-binding transcription factor activity, RNA polymerase II-specific1
DNA-binding transcription repressor activity1
protein binding1
nucleic acid binding1
transcription cis-regulatory region binding1
transcription regulator activity1
binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

252 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
MYPOPPFN1P07737622
MYPOPXPO6Q96QU8432
MYPOPEIF4E3Q8N5X7379
MYPOPPFN4Q8NHR9359
MYPOPPFN3P60673356
MYPOPGSDMCQ9BYG8351
MYPOPEMID1Q96A84349
MYPOPMKRN1Q9UHC7331
MYPOPSNNO75324327
MYPOPPFN2P35080326
MYPOPR3HDM1Q15032311
MYPOPCNNM2Q9H8M5296
MYPOPYLPM1P49750294
MYPOPZNF318Q5VUA4278
MYPOPDEFA5Q01523255

IntAct

122 interactions, top by confidence:

ABTypeScore
MYPOPPRR3psi-mi:“MI:0915”(physical association)0.560
NECAB2MYPOPpsi-mi:“MI:0915”(physical association)0.560
HNRNPKMYPOPpsi-mi:“MI:0915”(physical association)0.560
KRT40MYPOPpsi-mi:“MI:0915”(physical association)0.560
KHDRBS3MYPOPpsi-mi:“MI:0915”(physical association)0.560
MTUS2MYPOPpsi-mi:“MI:0915”(physical association)0.560
SAT1MYPOPpsi-mi:“MI:0915”(physical association)0.560
RBMY1A1MYPOPpsi-mi:“MI:0915”(physical association)0.560
TRA2BMYPOPpsi-mi:“MI:0915”(physical association)0.560
MYPOPMDFIpsi-mi:“MI:0915”(physical association)0.560
MYPOPCARD10psi-mi:“MI:0915”(physical association)0.560
RBMXMYPOPpsi-mi:“MI:0915”(physical association)0.560
KRTAP12-2MYPOPpsi-mi:“MI:0915”(physical association)0.560
NCK2MYPOPpsi-mi:“MI:0915”(physical association)0.560
TNS2MYPOPpsi-mi:“MI:0915”(physical association)0.560
KRTAP1-3MYPOPpsi-mi:“MI:0915”(physical association)0.560
TGM1MYPOPpsi-mi:“MI:0915”(physical association)0.560
RBPMS2MYPOPpsi-mi:“MI:0915”(physical association)0.560
CYSRT1MYPOPpsi-mi:“MI:0915”(physical association)0.560
MYPOPKRTAP10-8psi-mi:“MI:0915”(physical association)0.560
FHL3MYPOPpsi-mi:“MI:0915”(physical association)0.560
SYNCRIPMYPOPpsi-mi:“MI:0915”(physical association)0.560
HNRNPH1MYPOPpsi-mi:“MI:0915”(physical association)0.560
KRTAP10-7MYPOPpsi-mi:“MI:0915”(physical association)0.560
KRTAP19-6MYPOPpsi-mi:“MI:0915”(physical association)0.560
KRTAP5-6MYPOPpsi-mi:“MI:0915”(physical association)0.560
CIB4MYPOPpsi-mi:“MI:0915”(physical association)0.560
HOXA1MYPOPpsi-mi:“MI:0915”(physical association)0.560
MYPOPPRDM14psi-mi:“MI:0915”(physical association)0.560

BioGRID (55): MYPOP (Affinity Capture-MS), MYPOP (Affinity Capture-MS), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid), MYPOP (Two-hybrid)

ESM2 similar proteins: A0A0U1RQ45, A0A1B0GWB2, A2A9T0, A6QPA0, A7MCY6, D3ZFB6, E9PUL5, E9Q0B3, F5GYI3, F5H4A9, J3QNX5, O70142, P0C1G7, P81408, P97764, P98077, Q148V8, Q15654, Q2KI80, Q3SX26, Q3SZL6, Q4V9L6, Q5FVJ4, Q5FW56, Q5RAC1, Q5T7N3, Q6DG50, Q6PAJ3, Q6PJ61, Q6ZMQ8, Q6ZNR0, Q6ZRV2, Q75VX8, Q7Z6L0, Q86UK7, Q86VE0, Q8BGW2, Q8BRJ3, Q8BX43, Q8C0R7

Diamond homologs: Q08B72, Q86VE0, Q8R4U1

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 41 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Keratinization1123.6×3e-11

GO biological processes:

GO termPartnersFoldFDR
regulation of alternative mRNA splicing, via spliceosome545.2×2e-05
mRNA splicing, via spliceosome517.0×6e-04

Disease & clinical

Clinical variants and AI predictions

ClinVar

81 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance77
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

407 predictions. Top by Δscore:

VariantEffectΔscore
19:45891319:TGTAT:Tacceptor_gain1.0000
19:45891320:GTAT:Gacceptor_gain1.0000
19:45891321:TAT:Tacceptor_gain1.0000
19:45891322:AT:Aacceptor_gain1.0000
19:45891323:TCT:Tacceptor_loss1.0000
19:45891324:C:CCacceptor_gain1.0000
19:45891324:C:Tacceptor_loss1.0000
19:45891325:T:Aacceptor_loss1.0000
19:45891326:G:Cacceptor_gain0.9900
19:45891326:G:GCacceptor_gain0.9900
19:45901270:CTCA:Cdonor_loss0.9900
19:45901271:TCA:Tdonor_loss0.9900
19:45901272:CA:Cdonor_loss0.9900
19:45901273:A:Cdonor_loss0.9900
19:45901274:C:CAdonor_loss0.9900
19:45901273:A:ACdonor_gain0.9800
19:45901274:C:CCdonor_gain0.9800
19:45901274:CCTG:Cdonor_gain0.9800
19:45891320:GTATC:Gacceptor_gain0.9700
19:45891321:TATCT:Tacceptor_gain0.9700
19:45891322:ATCTG:Aacceptor_gain0.9700
19:45891323:TCTGT:Tacceptor_gain0.9700
19:45891324:CTGT:Cacceptor_gain0.9600
19:45891325:T:Gacceptor_gain0.9500
19:45895527:T:Cdonor_gain0.9500
19:45902568:A:ACdonor_gain0.9400
19:45902569:C:CCdonor_gain0.9400
19:45902563:CACT:Cdonor_loss0.9300
19:45902564:ACTC:Adonor_loss0.9300
19:45902565:CTCA:Cdonor_loss0.9300

AlphaMissense

2489 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:45901522:C:AK84N1.000
19:45901522:C:GK84N1.000
19:45901524:T:CK84E1.000
19:45901529:T:AD82V1.000
19:45901529:T:CD82G1.000
19:45901529:T:GD82A1.000
19:45901530:C:GD82H1.000
19:45901534:C:AW80C1.000
19:45901534:C:GW80C1.000
19:45901535:C:GW80S1.000
19:45901536:A:GW80R1.000
19:45901536:A:TW80R1.000
19:45901539:G:TR79S1.000
19:45901542:T:CK78E1.000
19:45901563:G:TR71S1.000
19:45901606:C:AW56C1.000
19:45901606:C:GW56C1.000
19:45901607:C:GW56S1.000
19:45901608:A:GW56R1.000
19:45901608:A:TW56R1.000
19:45901691:A:GL28P1.000
19:45901691:A:TL28Q1.000
19:45901703:T:AE24V1.000
19:45901714:G:CF20L1.000
19:45901714:G:TF20L1.000
19:45901715:A:CF20C1.000
19:45901715:A:GF20S1.000
19:45901716:A:GF20L1.000
19:45901510:C:AK88N0.999
19:45901510:C:GK88N0.999

dbSNP variants (sampled 300 via entrez): RS1000101153 (19:45902740 T>C,G), RS1000121350 (19:45894425 T>C), RS1000466884 (19:45894635 C>T), RS1000687419 (19:45899400 A>G), RS1000942052 (19:45889754 A>C), RS1001139379 (19:45901866 T>C,G), RS1001202556 (19:45899152 G>A), RS1001219501 (19:45894292 T>C), RS1001296159 (19:45894563 G>A), RS1001363725 (19:45897125 G>A), RS1001417410 (19:45890057 C>T), RS1001421339 (19:45902718 GC>G), RS1001571189 (19:45899833 T>G), RS1001798182 (19:45893405 C>A,G,T), RS1001809144 (19:45899561 C>A,T)

Disease associations

OMIM: gene MIM:617861 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST009798_38Asthma2.000000e-10

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

23 total (human), top 23 by PubMed support.

ChemicalActions (top 5)PubMed papers
Cisplatinaffects expression, affects cotreatment, increases expression2
FR900359increases phosphorylation1
bisphenol Fincreases expression1
dicrotophosincreases expression1
triphenyl phosphateaffects expression1
methylparabenincreases expression1
sodium arseniteincreases expression1
butyraldehydedecreases expression1
di-n-butylphosphoric acidaffects expression1
abrinedecreases expression1
jinfukangaffects cotreatment, increases expression1
Resveratrolaffects cotreatment, decreases expression1
Decitabineaffects expression1
Sunitinibincreases expression1
Benzo(a)pyreneincreases methylation1
Dichlorodiphenyl Dichloroethylenedecreases expression1
Diurondecreases expression1
Plant Extractsaffects cotreatment, decreases expression1
Smokedecreases expression1
Thiramincreases expression1
Tobacco Smoke Pollutiondecreases expression1
Tunicamycindecreases expression1
Valproic Acidincreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.